Mechanistic basis of heparin-induced thrombocytopenia

Seminars in Thoracic and Cardiovascular Surgery

Volumn 17, Issue 1, 2005, Pages 73-79

  Poncz, Mortimer ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FC RECEPTOR; HEPARIN; HEPARINOID; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; PROTAMINE SULFATE; THROMBOCYTE FACTOR 4;

ANTIBODY DETECTION; ANTIBODY PRODUCTION; ARTICLE; CLINICAL FEATURE; HEPARIN INDUCED THROMBOCYTOPENIA; HUMAN; IMMUNE RESPONSE; INFLAMMATION; MOUSE; NONHUMAN; PATHOGENESIS; PATHOPHYSIOLOGY; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN FUNCTION; PROTEIN SECRETION; THROMBOCYTE ACTIVATION; THROMBOCYTE ADHESION; THROMBOGENESIS; THROMBOSIS; VASCULAR ENDOTHELIUM;

EID: 17144369137     PISSN: 10430679     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.semtcvs.2004.12.007     Document Type: Review

References (77)

1. G.R. Rhodes R.H. Dixon D. Silver Heparin induced thrombocytopenia: Eight cases with thrombotic-hemorrhagic complications Ann Surg 186 1977 752-758
2. D.H. Lee T.E. Warkentin Frequency of heparin-induced thrombocytopenia in T. Warkentin A. Greinacher (eds) Heparin-Induced Thrombocytopenia 2000 Marcel-Decker, Inc New York, NY 107-148
3. J.M. Walenga W.P. Jeske H.L. Messmore Mechanisms of venous and arterial thrombosis in heparin-induced thrombocytopenia J Thromb Thrombolysis 10 2000 13-20
4. B.K. Phelan Heparin-associated thrombosis without thrombocytopenia Ann Intern Med 99 1983 637-638
5. T.E. Warkentin M.N. Levine J. Hirsh et al. Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin N Engl J Med 332 1995 1330-1335
6. T.E. Warkentin J.G. Kelton A 14-year study of heparin-induced thrombocytopenia Am J Med 101 1996 502-507
7. S. Nand W. Wong B. Yuen Heparin-induced thrombocytopenia with thrombosis: Incidence, analysis of risk factors, and clinical outcomes in 108 consecutive patients treated at a single institution Am J Hematol 56 1997 12-16
8. B.E. Lewis D.E. Wallis F. Leya et al. Argatroban-915 Investigators Argatroban anticoagulation in patients with heparin-induced thrombocytopenia Arch Intern Med 163 2003 1849-1856
9. N. Lubenow P. Eichler T. Lietz et al. Lepirudin for prophylaxis of thrombosis in patients with acute isolated heparin-induced thrombocytopenia: An analysis of three prospective studies Blood 2004 Epub
10. T.E. Warkentin R.S. Roberts J. Hirsh et al. An improved definition of immune heparin-induced thrombocytopenia in postoperative orthopedic patients Arch Intern Med 163 2003 2518-2524
11. E. Ling T.E. Warkentin Intraoperative heparin flushes and subsequent acute heparin-induced thrombocytopenia Anesthesiology 89 1998 1567-1569
12. J.L. Laster W.K. Nichols D. Silver Thrombocytopenia associated with heparin-coated catheters in patients with heparin-associated antiplatelet antibodies Arch Intern Med 149 1989 2285-2287
13. D.B. Cines P. Kaywin M. Bina et al. Heparin-associated thrombocytopenia N Engl J Med 303 1980 788-795
14. B.H. Chong P.A. Castaldi M.C. Berndt Heparin-induced thrombocytopenia: Effects of rabbit IgG, and its Fab and FC fragments on antibody-heparin-platelet interaction Thromb Res 55 1989 291-295
15. J.G. Kelton D. Sheridan A. Santos et al. Heparin-induced thrombocytopenia: Laboratory stories Blood 72 1988 925-930
16. J. Amiral F. Bridey M. Dreyfus et al. Platelet factor 4 complexed to heparin is the target for antibodies generated in heparin-induced thrombocytopenia Thromb Haemost 68 1992 95-96
17. A. Greinacher B. Potzsch J. Amiral et al. Heparin-associated thrombocytopenia: Isolation of the antibody and characterization of a multimolecular PF4-heparin complex as the major antigen Thromb Haemost 71 1994 247-251
18. 14C-serotonin release assay in the diagnosis of heparin-induced thrombocytopenia Am J Clin Pathol 104 1995 648-654
19. M.P. Reilly S.M. Taylor N.K. Hartman et al. Heparin-induced thrombocytopenia/thrombosis in a transgenic mouse model requires human platelet factor 4 and platelet activation through FcgammaRIIA Blood 98 2001 2442-2447
20. R.E. Merton D.P. Thomas S.J. Havercroft et al. High and low affinity heparin compared with unfractionated heparin as antithrombotic drugs Thromb Haemost 51 1984 254-256
21. D. Green G.J. Martin S.H. Shoichet et al. Thrombocytopenia in a prospective, randomized, double-blind trial of bovine and porcine heparin Am J Med Sci. 288 1984 60
22. A.K. Verma M. Levine S.J. Shalansky et al. Frequency of heparin-induced thrombocytopenia in critical care patients Pharmacotherapy 23 2003 745-753
23. C. Pouplard M.A. May S. Iochmann et al. Antibodies to platelet factor 4-heparin after cardiopulmonary bypass in patients anticoagulated with unfractionated heparin or a low-molecular-weight heparin: Clinical implications for heparin-induced thrombocytopenia Circulation 99 1999 2530-2536
24. T.E. Warkentin M.N. Levine J. Hirsh et al. Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin N Engl J Med 332 1995 1330-1335
25. E. Lindhoff-Last R. Nakov F. Misselwitz et al. Incidence and clinical relevance of heparin-induced antibodies in patients with deep vein thrombosis treated with unfractionated or low-molecular-weight heparin Br J Haematol 118 2002 1137-1142
26. J. Ansell N. Slepchuk Jr R. Kumar et al. Heparin induced thrombocytopenia: A prospective study Thromb Haemost 43 1980 61-65
27. P. Savi B.H. Chong A. Greinacher et al. Effect of fondaparinux on platelet activation in the presence of heparin-dependent antibodies. A blinded comparative multicenter study with unfractionated heparin Blood 2004 Epub
28. X. Zhang L. Chen D.P. Bancroft et al. Crystal structure of recombinant human platelet factor 4 Biochemistry 33 1994 8361-8366
29. G.P. Visentin M. Moghaddam S.E. Beery et al. Heparin is not required for detection of antibodies associated with heparin-induced thrombocytopenia/ thrombosis J Lab Clin Med 138 2001 22-31
30. A. Greinacher B. Potzsch J. Amiral et al. Heparin-associated thrombocytopenia: Isolation of the antibody and characterization of a multimolecular PF4-heparin complex as the major antigen Thromb Haemost 71 1994 247-251
31. L. Rauova M. Poncz S.E. McKenzie et al. Ultralarge complexes of heparin and PF4 are central to the pathogenesis of heparin-induced thrombocytopenia Blood 2004 Epub
32. M.K. Horne III B.R. Alkins Platelet binding of IgG from patients with heparin-induced thrombocytopenia J Lab Clin Med 127 1996 435-442
33. P. Romagnani L. Lasagni F. Annunziato et al. CXC chemokines: The regulatory link between inflammation and angiogenesis Trends Immunol 25 2004 201-209
34. A.R. Gear D. Camerini Platelet chemokines and chemokine receptors: Linking hemostasis, inflammation, and host defense Microcirculation 10 2003 335-350
35. L. Lasagni M. Francalanci F. Annunziato et al. An alternatively spliced variant of CXCR3 mediates the inhibition of endothelial cell growth induced by IP-10, Mig, and I-TAC, and acts as functional receptor for platelet factor 4 J Exp Med 197 2003 1537-1549
36. D.A. Lane H. Ireland S. Wolff et al. Detection of enhanced in vivo platelet alpha-granule release in different patient groups - Comparison of beta-thromboglobulin, platelet factor 4, and thrombospondin assays Thromb Haemost 52 1984 183-187
37. B. Rucinski L.C. Knight S. Niewiarowski Clearance of human platelet factor 4 by liver and kidney: Its alteration by heparin Am J Physiol 251 1986 H800-H807
38. X. Zhang L. Chen D.P. Bancroft et al. Crystal structure of recombinant human platelet factor crystal structure of recombinant human platelet factor 4 Biochemistry 33 1994 8361-8366
39. T.F. Deuel P.S. Keim M. Farmer et al. Amino acid sequence of human platelet factor 4 Proc Natl Acad Sci USA 74 1977 2256-2258
40. A. Slungaard Platelet factor 4 modulation of the thrombomodulin-protein C system Crit Care Med 32 2004 S331-S335
41. D. Stern P. Nawroth J. Marcum et al. Interaction of antithrombin III with bovine aortic segments. Role of heparin in binding and enhanced anticoagulant activity J Clin Invest 75 1985 272-279
42. I.R. Katz G.J. Thorbecke M.B. Zucker Alleviation of immunosuppression in vitro by recombinant platelet factor 4 Int Immunol 4 1992 183-190
43. B.S. Sachais A.A. Higazi D.B. Cines et al. Interactions of platelet factor 4 with the vessel wall Semin Thromb Hemost 30 2004 351-358
44. T.E. Maione G.S. Gray J. Petro et al. Inhibition of angiogenesis by recombinant human platelet factor-4 and related peptides Science 247 1990 77-79
45. S.T. Bebawy J. Gorka T.M. Hyers et al. In vitro effects of platelet factor 4 on normal human neutrophil functions J Leukoc Biol 39 1986 423-434
46. A.M. Gewirtz J. Zhang J. Ratajczak et al. Chemokine regulation of human megakaryocytopoiesis Blood 86 1995 2559-2567
47. D.E. Eslin C. Zhang K.J. Samuels et al. Transgenic mice studies demonstrate a role for Platelet Factor 4 in thrombosis: Dissociation between anticoagulant and antithrombotic effect of heparin Blood 2004 Epub
48. C. Zhang M.A. Thornton M.A. Kowalska et al. Localization of distal regulatory domains in the megakaryocyte-specific platelet basic protein/ platelet factor 4 gene locus Blood 98 2001 610-617
49. J.E. Gessner H. Heiken A. Tamm et al. The IgG Fc receptor family Ann Hematol 76 1998 231-248
50. P.A. Warmerdam J.G. van de Winkel A. Vlug et al. A single amino acid in the second Ig-like domain of the human Fc gamma receptor II is critical for human IgG2 binding J Immunol 147 1991 1338-1343
51. G.A. Denomme T.E. Warkentin P. Horsewood et al. Activation of platelets by sera containing IgG1 heparin-dependent antibodies: An explanation for the predominance of the Fc gamma RIIa "low responder" (His131) gene in patients with heparin-induced thrombocytopenia J Lab Clin Med 130 1997 278-284
52. J.K. Burgess R. Lindeman C.N. Chesterman et al. Single amino acid mutation of Fc gamma receptor is associated with the development of heparin-induced thrombocytopenia Br J Haematol 91 1995 761-766
53. G. Arepally S.E. McKenzie X.M. Jiang et al. Fc gamma RIIA H/R 131 polymorphism, subclass-specific IgG anti-heparin/platelet factor 4 antibodies and clinical course in patients with heparin-induced thrombocytopenia and thrombosis Blood 89 1997 370-375
54. C. Bachelot-Loza R. Saffroy D. Lasne et al. Importance of the FcgammaRIIa-Arg/His-131 polymorphism in heparin-induced thrombocytopenia diagnosis Thromb Haemost 79 1998 523-528
55. L.E. Carlsson S. Santoso G. Baurichter et al. Heparin-induced thrombocytopenia: New insights into the impact of the FcgammaRIIa-R-H131 polymorphism Blood 92 1998 1526-1531
56. T.A. Trikalinos F.B. Karassa J.P.A. Ioannidis Meta-analysis of the association between low-affinity Fc receptor gene polymorphisms and hematologic and autoimmune diseases Blood 98 2001 1634-1636
57. B.H. Chong R.L. Pilgrim M.A. Cooley et al. Increased expression of platelet IgG Fc receptors in immune heparin-induced thrombocytopenia Blood 81 1993 988-993
58. K.R. McCrae S.J. Shattil D.B. Cines Platelet activation induces increased Fc gamma receptor expression J Immunol 144 1990 3920-3927
59. L.E. Carlsson N. Lubenow C. Blumentritt et al. Platelet receptor and clotting factor polymorphisms as genetic risk factors for thromboembolic complications in heparin-induced thrombocytopenia Pharmacogenetics 13 2003 253-258
60. T.L. Bauer G. Arepally B.A. Konkle et al. Prevalence of heparin-associated antibodies without thrombosis in patients undergoing cardiopulmonary bypass surgery Circulation 95 1997 1242-1246
61. G.P. Visentin M. Malik K.A. Cyganiak et al. Patients treated with unfractionated heparin during open heart surgery are at high risk to form antibodies reactive with heparin: Platelet factor 4 complexes J Lab Clin Med 128 1996 376-383
62. T.E. Warkentin J.I. Sheppard P. Horsewood et al. Impact of the patient population on the risk for heparin-induced thrombocytopenia Blood 96 2000 1703-1708
63. C. Pouplard M.A. May S. Iochmann et al. Antibodies to platelet factor 4-heparin after cardiopulmonary bypass in patients anticoagulated with unfractionated heparin or a low-molecular-weight heparin: Clinical implications for heparin-induced thrombocytopenia Circulation 99 1999 2530-2536
64. G.P. Visentin S.E. Ford J.P. Scott et al. Antibodies from patients with heparin-induced thrombocytopenia/thrombosis are specific for platelet factor 4 complexed with heparin or bound to endothelial cells J Clin Invest 93 1994 81-88
65. G.P. Visentin Heparin-induced thrombocytopenia: Molecular pathogenesis Thromb Haemost 82 1999 448-456
66. J. Amiral C. Pouplard A.M. Vissac et al. Affinity purification of heparin-dependent antibodies to platelet factor 4 developed in heparin-induced thrombocytopenia: Biological characteristics and effects on platelet activation Br J Haematol 109 2000 336-341
67. Zwicker JI, Uhl L, Huang W-H, et al: Thrombosis and ELISA optical density values in hospitalized patients with heparin-induced thrombocytopenia. J Thromb Haemost (in press)
68. L. Ziporen Z.Q. Li K.S. Park et al. Defining an antigenic epitope on platelet factor 4 associated with heparin-induced thrombocytopenia Blood 92 1998 3250-3259
69. Z.Q. Li W. Liu K.S. Park et al. Defining a second epitope for heparin-induced thrombocytopenia/thrombosis antibodies using KKO, a murine HIT-like monoclonal antibody Blood 99 2002 1230-1236
70. J.S. Suh R.H. Aster G.P. Visentin Antibodies from patients with heparin-induced thrombo-cytopenia/thrombosis recognize different epitopes on heparin: Platelet factor 4 Blood 91 1998 916-922
71. G.M. Arepally S. Kamei K.S. Park et al. Characterization of a murine monoclonal antibody that mimics heparin-induced thrombocytopenia antibodies Blood 95 2000 1533-1540
72. D.B. Cines A. Tomaski S. Tannenbaum Immune endothelial-cell injury in heparin-associated thrombocytopenia N Engl J Med 316 1987 581-589
73. G.P. Visentin S.E. Ford J.P. Scott et al. Antibodies from patients with heparin-induced thrombocytopenia/thrombosis are specific for platelet factor 4 complexed with heparin or bound to endothelial cells J Clin Invest 93 1994 81-88
74. M. Blank Y. Shoenfeld S. Tavor et al. Anti-platelet factor 4/heparin antibodies from patients with heparin-induced thrombocytopenia provoke direct activation of microvascular endothelial cells Int Immunol 14 2002 121-129
75. J.M. Herbert P. Savi W.P. Jeske et al. Effect of SR121566A, a potent GP IIb-IIIa antagonist, on the HIT serum/heparin-induced platelet mediated activation of human endothelial cells Thromb Haemost 80 1998 326-331
76. C. Pouplard S. Iochmann B. Renard et al. Induction of monocyte tissue factor expression by antibodies to heparin-platelet factor 4 complexes developed in heparin-induced thrombocytopenia Blood 97 2001 3300-3302
77. G.M. Arepally I.M. Mayer Antibodies from patients with heparin-induced thrombocytopenia stimulate monocytic cells to express tissue factor and secrete interleukin-8 Blood 98 2001 1252-1254